Clinical Trials
21 trialsNCT06807619 2026-05-22
A Study of Sotorasib in People With Brain Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT05118854 2026-05-04
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05398094 2026-04-30
MERIT-lung
Fundación GECP
Phase 2 Recruiting
NCT07543172 2026-04-21
CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
NCT06249282 2026-04-03
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT06582771 2026-03-25
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT05845450 2026-03-12
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
Gruppo Oncologico del Nord-Ovest
Phase 2 Recruiting
NCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT06333678 2026-01-29
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT05815173 2025-12-30
Ladarixin With Sotorasib in Advanced NSCLC
NYU Langone Health
Phase 1 Recruiting
NCT05313009 2025-12-16
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Medical University of South Carolina
Phase 1/2 Terminated
NCT07124884 2025-08-15
COLOSOTO
Federation Francophone de Cancerologie Digestive
Phase 2 Not yet recruiting
NCT05631249 2025-05-08
CODEBREAK-IGR
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Recruiting
NCT06314763 2024-04-30
ROSIE
Radboud University Medical Center
Phase 4 Completed
NCT05815186 2024-03-29
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
NYU Langone Health
Phase 2 Withdrawn
NCT06127940 2023-11-13
K-SAB
Karolinska University Hospital
Phase 1 Unknown
NCT05311709 2023-11-09
SOLUCOM
Vestre Viken Hospital Trust
Phase 2 Unknown
NCT05993455 2023-08-15
A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Treatment With a Combination of Sotorasib and Panitumumab
Korea University Anam Hospital
Phase 2 Unknown
NCT05400577 2023-07-17
Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC
Fox Chase Cancer Center
Phase 2 Withdrawn
NCT05251038 2023-05-11
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer
Hoosier Cancer Research Network
Phase 1/2 Withdrawn
NCT05451056 2022-07-11
breakthrough
Yonsei University
Phase 2 Unknown